| Overview / Abstract: |
The landscape of AML treatment is evolving, and newer targeted agents may improve outcomes for selected subgroups of patients. Activity goal considerations for the nurse/NP when participating in this activity: Treatment decision making with incorporation of cytogenetic and molecular testing |
|
Expiration |
Jun 24, 2025 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE |
|
Format |
Online |
|
Credits / Hours |
1.0 |
|
Accreditation |
ANCC |
|
Presenters / Authors / Faculty |
Elizabeth M. Umbro, CRNP |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from AbbVie. |
|
Keywords / Search Terms |
American Academy of CME Acute Myeloid Leukemia Cytogenetic testing Molecular testing Nursing care Free CE CME |